Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2023 07:00 ET | Source: Destination XL Group, Inc.

Destination XL Group, Inc. Reports Holiday Sales Results

CANTON, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and shoes, today announced the...
January 09, 2023 07:00 ET | Source: Instil Bio

Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-306 in Lung, Ovarian, and Renal Cancer

Phase 1 trial of ITIL-306 in NSCLC, ovarian, and RCC re-opened to enrollment after voluntary pause Initial data readout for ITIL-306 expected in 2023 With recent reprioritization of clinical...
January 09, 2023 07:00 ET | Source: American Lithium Corp.

American Lithium confirms 99.4% purity lithium carbonate precipitation after 97.7% lithium leach extraction and overall Li recovery of 88.1% at TLC - Maiden PEA to be announced shortly

VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V:LI | OTCQB:LIACF | Frankfurt:5LA1) is pleased to announce results...
January 09, 2023 07:00 ET | Source: iTeos Therapeutics Inc.

iTeos Provides Business Updates and Clinical Development Plans for 2023

- 2023 will produce significant advances for both anti-TIGIT monoclonal antibody EOS-448/GSK4428859A and adenosine A2A receptor antagonist inupadenant - Eleven clinical trials planned or ongoing...
January 09, 2023 07:00 ET | Source: Axogen, Inc.

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

ALACHUA, Fla. and TAMPA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
January 09, 2023 07:00 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics Provides Updates on 2022 Twirla Performance and 2023 Commercial Plan

Fourth Quarter 2022 Twirla Factory Sales Expected to Increase Approximately 30% from Third Quarter 2022 Full Year 2022 Factory Sales Expected to Increase Approximately 232% from Full Year 2021 Full...
January 09, 2023 07:00 ET | Source: Abercrombie & Fitch Management Co.

Abercrombie & Fitch Co. Increases Fourth Quarter Sales and Operating Margin Outlook Based on Better-Than-Expected Holiday Sales

NEW ALBANY, Ohio, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE: ANF) today provided a business update and updated its outlook for the fourth quarter and full year of fiscal...
January 09, 2023 07:00 ET | Source: Kirby Corporation

Kirby Corporation Concludes Review of Strategic Alternatives for Distribution and Services Business; Remains Open to Opportunities to Maximize Shareholder Value

HOUSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Kirby Corporation (NYSE: KEX) ("Kirby" or the “Company”) today announced its Board of Directors has concluded the Company’s review of strategic...
January 09, 2023 07:00 ET | Source: Voyager Therapeutics, Inc.

Neurocrine Biosciences and Voyager Therapeutics Enter Strategic Collaboration for Development and Commercialization of Voyager’s GBA1 Program and Other Next-Generation Gene Therapies for Neurological Diseases

- Voyager to receive up-front consideration of $175 million including a $39 million equity investment, up to $1.5 billion in potential development milestones, additional potential commercial...
January 09, 2023 06:59 ET | Source: ReportLinker

The Global Healthcare Packaging Market is forecast to grow by $56.67 bn during 2022-2027, accelerating at a CAGR of 7.05% during the forecast period

New York, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Healthcare Packaging Market 2023-2027" -...

1 ...63075 63076 63077 ...316386